This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamaguchi, H.
Right arrow Articles by Wang, H.-G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamaguchi, H.
Right arrow Articles by Wang, H.-G.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, January 2006, p. 569-579, Vol. 26, No. 2
0270-7306/06/$08.00+0     doi:10.1128/MCB.26.2.569-579.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Tissue Transglutaminase Serves as an Inhibitor of Apoptosis by Cross-Linking Caspase 3 in Thapsigargin-Treated Cells

Hirohito Yamaguchi* and Hong-Gang Wang*

Drug Discovery Program, H. Lee Moffitt Cancer Center and Research Institute, Department of Interdisciplinary Oncology, University of South Florida College of Medicine, Tampa, Florida 33612

Received 26 May 2005/ Returned for modification 30 June 2005/ Accepted 18 October 2005

Thapsigargin (THG) is an inhibitor of the endoplasmic reticulum Ca2+-ATPase that induces caspase 3 activation and apoptosis in HCT116 cells through a Bax-dependent pathway. In Bax-deficient HCT116 cells, however, THG specifically generates two additional species of caspase 3, termed p40 and p64, with molecular masses of approximately 40 and 64 kDa, respectively, through unknown mechanisms. Here, we report that the Ca2+-dependent protein cross-linking enzyme tissue transglutaminase (tTGase) is involved in THG-induced p40 and p64 formation by catalyzing caspase 3 cross-linking reactions, thereby inactivating caspase 3 and apoptosis in Bax-deficient cells. Overexpression of tTGase increases p40 and p64 in THG-treated cells, and purified tTGase catalyzes procaspase 3 cross-linking in vitro. Inhibition of tTGase activity by either the tTGase inhibitor monodansylcadaverine or short-hairpin RNA reduces the cross-linked species p40 and p64 and restores caspase 3 activation in response to THG treatment. Moreover, prolonged exposure to THG results in a decrease in protein levels of XIAP and cIAP-1, which is subsequently followed by an increase in tTGase protein expression and activity. Expression of cytosolic Smac sensitizes Bax-deficient cells to THG-induced apoptosis; however, this effect is diminished by coexpression of tTGase. Taken together, these results suggest a novel role for tTGase as a new type of caspase 3 inhibitor in THG-mediated apoptosis.

* Corresponding author. Mailing address: Drug Discovery Program, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, Florida 33612. Phone: (813) 745-3231. Fax: (813) 979-7265. E-mail for Hong-Gang Wang: WangHG{at}moffitt.usf.edu. E-mail for Horihito Yamaguchi: YamaguH{at}moffitt.usf.edu.

Molecular and Cellular Biology, January 2006, p. 569-579, Vol. 26, No. 2
0022-538X/06/$08.00+0     doi:10.1128/MCB.26.2.569-579.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • CHHABRA, A., VERMA, A., MEHTA, K. (2009). Tissue Transglutaminase Promotes or Suppresses Tumors Depending on Cell Context. Anticancer Res 29: 1909-1919 [Abstract] [Full Text]  
  • Yamaguchi, H., Woods, N. T., Piluso, L. G., Lee, H.-H., Chen, J., Bhalla, K. N., Monteiro, A., Liu, X., Hung, M.-C., Wang, H.-G. (2009). p53 Acetylation Is Crucial for Its Transcription-independent Proapoptotic Functions. J. Biol. Chem. 284: 11171-11183 [Abstract] [Full Text]  
  • Cao, L., Petrusca, D. N., Satpathy, M., Nakshatri, H., Petrache, I., Matei, D. (2008). Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling. Carcinogenesis 29: 1893-1900 [Abstract] [Full Text]  
  • Ai, L., Kim, W.-J., Demircan, B., Dyer, L. M., Bray, K. J., Skehan, R. R., Massoll, N. A., Brown, K. D. (2008). The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer. Carcinogenesis 29: 510-518 [Abstract] [Full Text]  
  • Antonyak, M. A., Jansen, J. M., Miller, A. M., Ly, T. K., Endo, M., Cerione, R. A. (2006). Two isoforms of tissue transglutaminase mediate opposing cellular fates. Proc. Natl. Acad. Sci. USA 103: 18609-18614 [Abstract] [Full Text]  
  • Kim, D.-S., Park, S.-S., Nam, B.-H., Kim, I.-H., Kim, S.-Y. (2006). Reversal of Drug Resistance in Breast Cancer Cells by Transglutaminase 2 Inhibition and Nuclear Factor-{kappa}B Inactivation.. Cancer Res. 66: 10936-10943 [Abstract] [Full Text]  
  • Fok, J. Y., Ekmekcioglu, S., Mehta, K. (2006). Implications of tissue transglutaminase expression in malignant melanoma.. Molecular Cancer Therapeutics 5: 1493-1503 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»